4519
▲ PositiveCapitalrelevance
Chugai reported a 19% rise in first-half net profit and a 20% rise in Q2 net profit, with stable margins.
Chugai Pharmaceutical reported consolidated net profit for the cumulative first half of the fiscal year ending December 2026 rose 19.2% year-on-year to 231.7 billion yen. For the April–June quarter, consolidated net profit increased 19.7% year-on-year to 116.3 billion yen, with the operating profit margin on sales unchanged from the previous year's 47.1% at 47.1%.
Chugai reported a 19% rise in first-half net profit and a 20% rise in Q2 net profit, with stable margins.